基本信息
浏览量:462
职业迁徙
个人简介
Prof. Boris Hadaschik studied medicine in Heidelberg, Louisville, Detroit, and New Orleans. Afterward, he trained in Surgery and Urology in Heidelberg and Mainz.
In 2006, Boris Hadaschik was awarded a two-year postdoctoral research fellowship at the Vancouver Prostate Centre from the German Research Foundation.
He obtained the German Urological Association’s highest scientific award, the Maximilian Nitze Prize, for his work regarding "Novel intravesical agents against non-muscle invasive bladder cancer in a validated orthotopic mouse model".
In 2010, Boris Hadaschik became an Associate Professor in the Department of Urology at the University Hospital Heidelberg.
His main interests lie in the development of prostate cancer diagnostics (for example, imaging-guided biopsy) and therapy (for example, molecularly-targeted radiopharmaceuticals) to improve and customize cancer treatment and its outcomes.
Prof. Boris Hadaschik is a Co-Founder of the Ginsburg Study Group for Comprehensive Prostate Diagnostics and a Member of several international Working Groups to optimize MRI-targeted prostate biopsy.
In addition, he is a Principal Investigator of the German multicentre PROBASE trial for prospective randomized evaluation of risk-adapted prostate-specific antigen screening in 50,000 young men.
In 2006, Boris Hadaschik was awarded a two-year postdoctoral research fellowship at the Vancouver Prostate Centre from the German Research Foundation.
He obtained the German Urological Association’s highest scientific award, the Maximilian Nitze Prize, for his work regarding "Novel intravesical agents against non-muscle invasive bladder cancer in a validated orthotopic mouse model".
In 2010, Boris Hadaschik became an Associate Professor in the Department of Urology at the University Hospital Heidelberg.
His main interests lie in the development of prostate cancer diagnostics (for example, imaging-guided biopsy) and therapy (for example, molecularly-targeted radiopharmaceuticals) to improve and customize cancer treatment and its outcomes.
Prof. Boris Hadaschik is a Co-Founder of the Ginsburg Study Group for Comprehensive Prostate Diagnostics and a Member of several international Working Groups to optimize MRI-targeted prostate biopsy.
In addition, he is a Principal Investigator of the German multicentre PROBASE trial for prospective randomized evaluation of risk-adapted prostate-specific antigen screening in 50,000 young men.
研究兴趣
论文共 680 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ludmila Santiago Almeida, Elba Cristina Sa de Camargo Etchebehere, Irene Garcia Megias,Adriana K. Calapaqui Teran,Boris Hadaschik,Patrick M. Colletti,Ken Herrmann,Francesco Giammarile,Roberto C. Delgado Bolton
CLINICAL NUCLEAR MEDICINEno. 1 (2024): 45-55
R. Seifert, A. Gafita, T. Telli,Andrew Voter, K. Herrmann,Martin Pomper,B. Hadaschik,Steven P. Rowe, W. P. Fendler
Die Urologieno. 1 (2024): 67-74
ARAB JOURNAL OF UROLOGYno. 1 (2024): 61-69
Clinical and Translational Imagingno. 1 (2024): 1-3
Die Urologieno. 5 (2023): 464-472
引用2浏览0引用
2
0
Urologie (Heidelberg, Germany)no. 12 (2023): 1267-1268
引用0浏览0WOS引用
0
0
Journal of robotic surgeryno. 5 (2023): 2089-2098
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn